Publications
Detailed Information
Presence of Membrane-Bound TGF-β1 and Its Regulation by IL-2-Activated Immune Cell-Derived IFN-γ in Head and Neck Squamous Cell Carcinoma Cell Lines
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Ahn, Yong-Oon | - |
dc.contributor.author | Lee, June-Chul | - |
dc.contributor.author | Sung, Myung-Whun | - |
dc.contributor.author | Heo, Dae Seog | - |
dc.date.accessioned | 2012-05-24T06:31:36Z | - |
dc.date.available | 2012-05-24T06:31:36Z | - |
dc.date.issued | 2009-05-15 | - |
dc.identifier.citation | JOURNAL OF IMMUNOLOGY; Vol.182 10; 6114-6120 | ko_KR |
dc.identifier.issn | 0022-1767 | - |
dc.identifier.uri | https://hdl.handle.net/10371/76425 | - |
dc.description.abstract | The presence of membrane-bound TGF-beta 1 (mTGF-beta 1) has been recently observed in regulatory T cells, but only a few studies have reported the same phenomenon in cancer cells. In this study, we investigate the regulation of mTGF-beta l expression in five head and neck squamous cell carcinoma cell lines using FACS analysis. Through blocking Ab and exogenous cytokine treatment experiments, we found that expression of mTGF-beta 1 is significantly induced by the activated immune cell-derived factor IFN-gamma. In addition, IFN-gamma and TNF-alpha are shown to have a synergistic effect on mTGF-beta 1 expression. Moreover, we found that exogenous TNF-alpha induces endogenous TNF-alpha mRNA expression in an autocrine loop. In contrast to previous reports, we confirm that, in this model, mTGF-beta 1 is neither a rebound form of once-secreted TGF-beta 1 nor an activated form of its precursor membrane latency-associated peptide. Inhibitors of transcription (actinomycin D), translation (cycloheximide), or membrane translocation (brefeldin A) effectively block the induction of mTGF-beta 1, which suggests that induction of mTGF-beta 1 by IFN-gamma and/or TNF-alpha occurs through de novo synthesis. These findings suggest that some cancer cells can detect immune activating cytokines, such as IFN-gamma and TNF-alpha, and actively block antitumor immunity by induction of mTGF-beta 1. The Journal of Immunology, 2009, 182: 6114-6120. | ko_KR |
dc.description.sponsorship | This study was supported by grants from the Innovative Research Institute for Cell
Therapy (A062260) and the Korea Health 21 Research & Development Project (02- PJ1-PG3-21206-0003), Ministry of Health and Welfare, Republic of Korea. | ko_KR |
dc.language.iso | en | ko_KR |
dc.publisher | AMER ASSOC IMMUNOLOGISTS | ko_KR |
dc.title | Presence of Membrane-Bound TGF-β1 and Its Regulation by IL-2-Activated Immune Cell-Derived IFN-γ in Head and Neck Squamous Cell Carcinoma Cell Lines | ko_KR |
dc.type | Article | ko_KR |
dc.contributor.AlternativeAuthor | 안용운 | - |
dc.contributor.AlternativeAuthor | 이준철 | - |
dc.contributor.AlternativeAuthor | 성명훈 | - |
dc.contributor.AlternativeAuthor | 허대석 | - |
dc.identifier.doi | 10.4049/jimmunol.0803725 | - |
dc.citation.journaltitle | JOURNAL OF IMMUNOLOGY | - |
dc.description.citedreference | Vila-del Sol V, 2008, J IMMUNOL, V181, P4461 | - |
dc.description.citedreference | Andersson J, 2008, J EXP MED, V205, P1975, DOI 10.1084/jem.20080308 | - |
dc.description.citedreference | Turley EA, 2008, NAT CLIN PRACT ONCOL, V5, P280, DOI 10.1038/ncponc1089 | - |
dc.description.citedreference | Baker K, 2008, INT J CANCER, V122, P1695, DOI 10.1002/ijc.23312 | - |
dc.description.citedreference | Marigo I, 2008, IMMUNOL REV, V222, P162 | - |
dc.description.citedreference | Teicher BA, 2007, CLIN CANCER RES, V13, P6247, DOI 10.1158/1078-0432.CCR-07-1654 | - |
dc.description.citedreference | Lim DS, 2007, CANCER IMMUNOL IMMUN, V56, P1817, DOI 10.1007/s00262-007-0325-0 | - |
dc.description.citedreference | Wrzesinski SH, 2007, CLIN CANCER RES, V13, P5262, DOI 10.1158/1078-0432.CCR-07-1157 | - |
dc.description.citedreference | Filipazzi P, 2007, J CLIN ONCOL, V25, P2546, DOI 10.1200/JCO.2006.08.5829 | - |
dc.description.citedreference | Gandhi R, 2007, J IMMUNOL, V178, P4017 | - |
dc.description.citedreference | Yu H, 2007, NAT REV IMMUNOL, V7, P41, DOI 10.1038/nri1995 | - |
dc.description.citedreference | Menoret A, 2006, J IMMUNOL, V177, P6091 | - |
dc.description.citedreference | Patterson SG, 2006, ONCOGENE, V25, P6113, DOI 10.1038/sj.onc.1209632 | - |
dc.description.citedreference | Jakowlew SB, 2006, CANCER METAST REV, V25, P435, DOI 10.1007/s10555-006-9006-2 | - |
dc.description.citedreference | Broderick L, 2006, J IMMUNOL, V177, P3082 | - |
dc.description.citedreference | Robinson CM, 2006, CYTOKINE, V35, P53, DOI 10.1016/j.cyto.2006.07.007 | - |
dc.description.citedreference | Hanada T, 2006, J EXP MED, V203, P1391, DOI 10.1084/jem.2006.0436 | - |
dc.description.citedreference | Dasgupta S, 2006, J CELL BIOCHEM, V97, P1036, DOI 10.1002/jcb.20647 | - |
dc.description.citedreference | Smyth MJ, 2006, J IMMUNOL, V176, P1582 | - |
dc.description.citedreference | Bui JD, 2006, J IMMUNOL, V176, P905 | - |
dc.description.citedreference | Li MO, 2006, ANNU REV IMMUNOL, V24, P99, DOI 10.1146/annurev.immunol.24.021605.090737 | - |
dc.description.citedreference | Kulbe H, 2005, CANCER RES, V65, P10355, DOI 10.1158/0008-5472.CAN-05-0957 | - |
dc.description.citedreference | Thomas DA, 2005, CANCER CELL, V8, P369, DOI 10.1016/j.ccr.2005.10.012 | - |
dc.description.citedreference | Ghiringhelli F, 2005, J EXP MED, V202, P1075, DOI 10.1084/jem.20051511 | - |
dc.description.citedreference | Dasgupta S, 2005, J IMMUNOL, V175, P5541 | - |
dc.description.citedreference | Hagemann T, 2005, J IMMUNOL, V175, P1197 | - |
dc.description.citedreference | VILADELSOL V, 2005, J IMMUNOL, V174, P2825 | - |
dc.description.citedreference | Balkwill F, 2004, NAT REV CANCER, V4, P540, DOI 10.1038/nrc1388 | - |
dc.description.citedreference | Lu SL, 2004, CANCER RES, V64, P4405 | - |
dc.description.citedreference | Lee JC, 2004, J IMMUNOL, V172, P7335 | - |
dc.description.citedreference | Nakamura K, 2004, J IMMUNOL, V172, P834 | - |
dc.description.citedreference | Williams L, 2004, J IMMUNOL, V172, P567 | - |
dc.description.citedreference | Leu CM, 2003, ONCOGENE, V22, P7809, DOI 10.1038/sj.onc.1207084 | - |
dc.description.citedreference | Roberts AB, 2003, P NATL ACAD SCI USA, V100, P8621, DOI 10.1073/pnas.1633291100 | - |
dc.description.citedreference | Castriconi R, 2003, P NATL ACAD SCI USA, V100, P4120, DOI 10.1073/pnas.0730604100 | - |
dc.description.citedreference | Dong HD, 2002, NAT MED, V8, P793, DOI 10.1038/nm730 | - |
dc.description.citedreference | Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780 | - |
dc.description.citedreference | Niu GL, 2002, ONCOGENE, V21, P2000, DOI 10.1038/sj/onc/1205260 | - |
dc.description.citedreference | Nakamura K, 2001, J EXP MED, V194, P629 | - |
dc.description.citedreference | Hasegawa Y, 2001, CANCER, V91, P964 | - |
dc.description.citedreference | Grainger DJ, 2000, CYTOKINE GROWTH F R, V11, P133 | - |
dc.description.citedreference | Kim SJ, 2000, CYTOKINE GROWTH F R, V11, P159 | - |
dc.description.citedreference | Khalil N, 1999, MICROBES INFECT, V1, P1255 | - |
dc.description.citedreference | Ku JL, 1999, LARYNGOSCOPE, V109, P976 | - |
dc.description.citedreference | Munger JS, 1999, CELL, V96, P319 | - |
dc.description.citedreference | Wikstrom P, 1998, PROSTATE, V37, P19 | - |
dc.description.citedreference | Fakhrai H, 1996, P NATL ACAD SCI USA, V93, P2909 | - |
dc.description.citedreference | HEO DS, 1989, CANCER RES, V49, P5167 | - |
dc.description.tc | 3 | - |
- Appears in Collections:
- Files in This Item:
- There are no files associated with this item.
Item View & Download Count
Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.